跳至主要内容
临床试验/NCT06708806
NCT06708806已完成不适用

Cell Ongrowth and Biocompatibility Study of Two Different (Hydrophobic Acrylic) Intraocular Lenses: IOL XY1 vs. IOL XY1A

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年4月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Foreign Body Giant Cells

研究概览

简要总结

The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Bilateral age-related cataract for which phacoemulsification extraction and posterior IOL implantation is planned
  • •Age 40 and older
  • •Astigmatism of at least 0.75Diopters in one eye
  • •Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant

排除标准

  • •Diabetes mellitus
  • •Pseudoexfoliation syndrome
  • •Systemical anticoagulation
  • •Antiphlogistic therapy
  • •Antiglaucomatosa
  • •Uncontrolled systemic or ocular disease
  • •Preceding ocular surgery or trauma
  • •Intraoperative complications
  • •Pregnancy/Nursing
  • •Concurrently participating in any other clinical trial or if they have participated in any other clinical trial during the last 30 days

研究组 & 干预措施

Toric vs Monofocal IOL

Other

The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. In Arm one (I) participants will receive a monofocal IOL (XY1) vs. an toric IOL (XY1A)

干预措施: cataract surgery (Procedure)

结局指标

主要结局

Foreign Body Giant Cells

时间窗: 6 weeks

The primary objective is to assess the difference in Foreign Body Giant Cells between monofocal and toric lenses in every patient at 6 weeks follow up.

次要结局

  • Foreign Body Giant Cells(5 months)
  • small round cells(5 months)
  • PCO(5 months)
  • anterior chamber reaction(5 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christina Leydolt

Assoc. Prof. Priv. Doz. Dr.

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验